UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Obligatory roles of dopamine D1 receptors in the dentate gyrus in antidepressant actions of a selective serotonin reuptake inhibitor, fluoxetine

Molecular psychiatry, 2020-06, Vol.25 (6), p.1229-1244

2020

Volltextzugriff (PDF)

Potential for targeting dopamine/DARPP-32 signaling in neuropsychiatric and neurodegenerative disorders

Expert opinion on therapeutic targets, 2017-03, Vol.21 (3), p.259-272

2017

Volltextzugriff (PDF)

Improvement of the learning effectiveness of pharmacology role-play by introducing P-drug reports

Folia Pharmacologica Japonica, 2023, Vol.158(2), pp.128-133

2023

Volltextzugriff (PDF)

Distinct Roles of PDE4 and PDE10A in the Regulation of cAMP/PKA Signaling in the Striatum

The Journal of neuroscience, 2008-10, Vol.28 (42), p.10460-10471

2008

Volltextzugriff (PDF)

Subregion-Specific Regulation of Dopamine D1 Receptor Signaling in the Striatum: Implication for L-DOPA-Induced Dyskinesia

The Journal of neuroscience, 2021-07, Vol.41 (30), p.6388-6414

2021

Volltextzugriff (PDF)

Adolescent psychosocial stress enhances sensitization to cocaine exposure in genetically vulnerable mice

Neuroscience research, 2020-02, Vol.151, p.38-45

2020

Volltextzugriff (PDF)

Chronic Fluoxetine Induces the Enlargement of Perforant Path-Granule Cell Synapses in the Mouse Dentate Gyrus

PloS one, 2016-01, Vol.11 (1), p.e0147307-e0147307

2016

Volltextzugriff (PDF)

Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex

Psychopharmacologia, 2012-02, Vol.219 (4), p.1065-1079

2012

Volltextzugriff (PDF)

Sex Differences in Dendritic Spine Formation in the Hippocampus and Animal Behaviors in a Mouse Model of Hyperthyroidism

Frontiers in cellular neuroscience, 2020-09, Vol.14, p.268-268

2020

Volltextzugriff (PDF)

Acute effects of resveratrol to enhance cocaine-induced dopamine neurotransmission in the striatum

Neuroscience letters, 2013-05, Vol.542, p.107-112

2013

Volltextzugriff (PDF)

Treatment of the Psychostimulant‐Sensitized Animal Model of Schizophrenia

CNS neuroscience & therapeutics, 2011-04, Vol.17 (2), p.133-139

2011

Volltextzugriff (PDF)

Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons

Neuropharmacology, 2012-12, Vol.63 (7), p.1248-1257

2012

Volltextzugriff (PDF)

Thromboxane receptor activation enhances striatal dopamine release, leading to suppression of GABAergic transmission and enhanced sugar intake

The European journal of neuroscience, 2011-08, Vol.34 (4), p.594-604

2011

Volltextzugriff (PDF)

Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist

Neuropharmacology, 2006-06, Vol.50 (8), p.991-997

2006

Volltextzugriff (PDF)

Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats

The European journal of neuroscience, 2008-05, Vol.27 (10), p.2551-2557

2008

Volltextzugriff (PDF)

Mechanisms for the Modulation of Dopamine D1 Receptor Signaling in Striatal Neurons

Frontiers in neuroanatomy, 2011-07, Vol.5

2011

Volltextzugriff (PDF)

DARPP-32/protein phosphatase 1 regulates Rasgrp2 as a novel component of dopamine D1 receptor signaling in striatum

Neurochemistry international, 2023-01, Vol.162, p.105438-105438, Article 105438

2023

Volltextzugriff (PDF)

Regulation of DARPP-32 phosphorylation by three distinct dopamine D₁-like receptor signaling pathways in the neostriatum

Journal of neurochemistry, 2008-11, Vol.107 (4), p.1014-1026

2008

Volltextzugriff (PDF)

Inhibition of STAT-mediated cytokine responses to chemically-induced colitis prevents inflammation-associated neurobehavioral impairments

Brain, behavior, and immunity, 2023-11, Vol.114, p.173-186

2023

Volltextzugriff (PDF)

Treatment of the Psychostimulant-Sensitized Animal Model of Schizophrenia: Treatment of Sensitization

CNS neuroscience & therapeutics, 2011-04, Vol.17 (2), p.133-139

2011

Volltextzugriff (PDF)

Treatment of the Psychostimulant-Sensitized Animal Model of Schizophrenia: SCHIZOPHRENIA: DIAGNOSIS AND TREATMENT

CNS neuroscience & therapeutics, 2011, Vol.17 (2), p.133-139

2011

Volltextzugriff (PDF)

P-drugレポート導入による薬理学ロールプレイの学習効果の向上

日本薬理学雑誌, 2023, Vol.158(2), pp.128-133

2023

Volltextzugriff (PDF)

Prostaglandin E2 Acts on EP1 Receptor and Amplifies Both Dopamine D1 and D2 Receptor Signaling in the Striatum

The Journal of neuroscience, 2007-11, Vol.27 (47), p.12900-12907

2007

Volltextzugriff (PDF)

Regulation of DARPP‐32 phosphorylation by three distinct dopamine D 1 ‐like receptor signaling pathways in the neostriatum

Journal of neurochemistry, 2008-11, Vol.107 (4), p.1014-1026

2008

Volltextzugriff (PDF)

P2-4-1 Effects of resveratrol on cocaine-induced dopamine D1 receptor signaling in the Striatum

Journal of Pharmacological Sciences, 2012, Vol.118 (suppl), p.184-184

2012

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(57)

Sprache

Japanisch
(40)
Englisch
(35)

Erscheinungsjahr

n.n

Thema

Animals
(21)
Science & Technology
(18)
Life Sciences & Biomedicine
(17)
Male
(16)
Neurosciences
(16)
Neurosciences & Neurology
(15)
Mice
(13)
Dopamine
(12)
Darpp-32
(11)
Mice, Inbred C57bl
(10)
Striatum
(9)
Corpus Striatum - Metabolism
(7)
Dopamine And Camp-Regulated Phosphoprotein 32 - Metabolism
(7)
Phosphorylation
(7)
Corpus Striatum - Drug Effects
(6)
Dopamine - Metabolism
(6)
Humans
(6)
Pka
(6)
Receptors, Dopamine D1 - Metabolism
(6)
Signal Transduction - Physiology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Obligatory roles of dopamine D1 receptors in the dentate gyrus in antidepressant actions of a selective serotonin reuptake inhibitor, fluoxetine

Potential for targeting dopamine/DARPP-32 signaling in neuropsychiatric and neurodegenerative disorders

Improvement of the learning effectiveness of pharmacology role-play by introducing P-drug reports

Distinct Roles of PDE4 and PDE10A in the Regulation of cAMP/PKA Signaling in the Striatum

Subregion-Specific Regulation of Dopamine D1 Receptor Signaling in the Striatum: Implication for L-DOPA-Induced Dyskinesia

Adolescent psychosocial stress enhances sensitization to cocaine exposure in genetically vulnerable mice

Chronic Fluoxetine Induces the Enlargement of Perforant Path-Granule Cell Synapses in the Mouse Dentate Gyrus

Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex

Sex Differences in Dendritic Spine Formation in the Hippocampus and Animal Behaviors in a Mouse Model of Hyperthyroidism

Acute effects of resveratrol to enhance cocaine-induced dopamine neurotransmission in the striatum

Treatment of the Psychostimulant‐Sensitized Animal Model of Schizophrenia

Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons

Thromboxane receptor activation enhances striatal dopamine release, leading to suppression of GABAergic transmission and enhanced sugar intake

Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist

Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats

Mechanisms for the Modulation of Dopamine D1 Receptor Signaling in Striatal Neurons

DARPP-32/protein phosphatase 1 regulates Rasgrp2 as a novel component of dopamine D1 receptor signaling in striatum

Regulation of DARPP-32 phosphorylation by three distinct dopamine D₁-like receptor signaling pathways in the neostriatum

Inhibition of STAT-mediated cytokine responses to chemically-induced colitis prevents inflammation-associated neurobehavioral impairments

Treatment of the Psychostimulant-Sensitized Animal Model of Schizophrenia: Treatment of Sensitization

Treatment of the Psychostimulant-Sensitized Animal Model of Schizophrenia: SCHIZOPHRENIA: DIAGNOSIS AND TREATMENT

P-drugレポート導入による薬理学ロールプレイの学習効果の向上

Prostaglandin E2 Acts on EP1 Receptor and Amplifies Both Dopamine D1 and D2 Receptor Signaling in the Striatum

Regulation of DARPP‐32 phosphorylation by three distinct dopamine D 1 ‐like receptor signaling pathways in the neostriatum

P2-4-1 Effects of resveratrol on cocaine-induced dopamine D1 receptor signaling in the Striatum

Suchergebnisse filtern